Table 3.
Echocardiographic data in study population at baseline and post marathon (n = 25)
| Echo parameters | Baseline | Post-race | Follow-up | p-value |
|---|---|---|---|---|
|
LV parameters (2D TTE) | ||||
| LVEDD (mm) |
50 ± 3 |
51 ± 5 |
50 ± 4 |
0.93 |
| LVESD (mm) |
33 ± 5 |
34 ± 4 |
32 ± 5 |
0.82 |
| LVEDV (ml) |
114 ± 12 |
110 ± 10 |
112 ± 11 |
0.72 |
| LVESV (ml) |
39 ± 11 |
38 ± 13 |
40 ± 11 |
0.77 |
| IVS (mm) |
9 ± 2 |
9 ± 1 |
9 ± 2 |
0.82 |
| PWT (mm) |
9 ± 1 |
8 ± 2 |
9 ± 2 |
0.71 |
| LVEF (%) |
63 ± 4 |
62 ± 6 |
64 ± 3 |
0.79 |
| LV mass/BSA (g/m2) |
102 ± 11 |
103 ± 15 |
99 ± 17 |
0.49 |
|
LA parameters (2D TTE) | ||||
| LA diameter (mm) |
36 ± 4 |
37 ± 3 |
36 ± 5 |
0.66 |
| LA volume (ml) |
42 ± 11 |
44 ± 13 |
40 ± 13 |
0.44 |
|
RA and RV parameters (2D TTE) | ||||
| RA volume (ml) |
37 ± 12 |
61 ± 12 |
31 ± 13 |
0.01* |
| RVEDD (mm) |
27 ± 3 |
45 ± 2 |
32 ± 4 |
0.02* |
| RV FAC (%) |
48 ± 3 |
29 ± 6 |
49 ± 4 |
0.01* |
| TAPSE (mm) | 2.3 ± 0.4 | 1.4 ± 0.2 | 2.1 ± 0.3 | 0.02* |
Data are expressed as mean ± SD. *p < 0.05, after the race vs. baseline.
2D, 2 dimensional; TTE, transthoracic echocardiography; LVEDD, LV end-diastolic diameter; LVESD, LV end-systolic diameter; LVEDV, LV end-diastolic volume; LVESV, LV end-systolic volume; IVS, interventricular septum; PWT, posterior wall thickness; LVEF, LV ejection fraction; BSA, body surface area; LA, left atrium; RA, right atrium; RVEDD, RV end-diastolic diameter; FAC, fractional area change; TAPSE, tricuspid annular plane systolic excursion.